Literature DB >> 6370711

Transplantation of chromosomally marked syngeneic marrow cells into mice not subjected to hematopoietic stem cell depletion.

D F Saxe, S S Boggs, D R Boggs.   

Abstract

The percentage of donor-host chimerism was determined 4-6 weeks or six months after injection of normal bone marrow cells into normal syngeneic or coisogeneic recipient mice. Donor-recipient pairs had chromosome markers that provided easy identification of metaphase cells. The percentage of donor cells in marrow or spleen ranged from 0 to 16% and this percentage was independent of the age of recipient or attempts to stimulate hematopoiesis in donor and/or host mice. In adult C57BL/6 mice there was a roughly linear dose-response relationship between cell dose and percentage of chimerism. There was no apparent dose-response relationship for AKR mice. The percentage of donor cells in the spleen was correlated to that seen in the marrow of recipients. Neonatal mice given the same intraperitoneal marrow cell dose as weanlings, but a larger number of cells relative to their own marrow mass, did not show a larger percentage of chimerism than weanlings. Similarly, weanlings given the same intravenous dose as adults showed no greater degree of chimerism than adults. Temporary anemia, induced by bleeding donors prior to cell collection, or more chronic hemopoietic stimulus (produced by injecting recipients with phenylhydrazine prior to cell injection with subsequent bleeding at intervals) did not result in an increased percentage of chimerism. These results indicate that there are "empty" sites in bone marrow of normal mice in which injected hematopoietic stem cells can lodge and grow.

Entities:  

Mesh:

Year:  1984        PMID: 6370711

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  15 in total

Review 1.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Simultaneous bone marrow and intestine transplantation promotes marrow-derived hematopoietic stem cell engraftment and chimerism.

Authors:  Atsunori Nakao; Hideyoshi Toyokawa; Kei Kimizuka; Michael A Nalesnik; Isao Nozaki; Robert J Bailey; Anthony J Demetris; Thomas E Starzl; Noriko Murase
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

3.  In Vivo Growing of New Cell Colonies in a Portion of Bone Marrow: Potential Use for Indirect Cell Therapy.

Authors:  Ana Manzanedo; Fidel Rodriguez; Jose A Obeso; Manuel Rodriguez
Journal:  Cell Med       Date:  2010-11-05

4.  Purified hematopoietic stem cell transplantation: the next generation of blood and immune replacement.

Authors:  Agnieszka Czechowicz; Irving L Weissman
Journal:  Hematol Oncol Clin North Am       Date:  2011-02       Impact factor: 3.722

5.  Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts.

Authors:  T Sakamoto; Q Ye; L Lu; A J Demetris; T E Starzl; N Murase
Journal:  Transplantation       Date:  1999-03-27       Impact factor: 4.939

6.  Busulfan pharmacokinetics, toxicity, and low-dose conditioning for autologous transplantation of genetically modified hematopoietic stem cells in the rhesus macaque model.

Authors:  Elizabeth M Kang; Matthew M Hsieh; Mark Metzger; Allen Krouse; Robert E Donahue; Michel Sadelain; John F Tisdale
Journal:  Exp Hematol       Date:  2006-02       Impact factor: 3.084

7.  Influence of timing of administration of 5-fluorouracil to donors on bone marrow engraftment in nonmyeloablated hosts.

Authors:  L D'Hondt; J Carlson; B Benoit; J Reilly; C Grimaldi; J Wuu; J F Lambert; M S Dooner; P J Quesenberry
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

Review 8.  Low dose total body irradiation followed by allogeneic lymphocyte infusion for refractory hematologic malignancy--an updated review.

Authors:  Karen K Ballen; Gerald Colvin; David Porter; Peter J Quesenberry
Journal:  Leuk Lymphoma       Date:  2004-05

9.  Niche recycling through division-independent egress of hematopoietic stem cells.

Authors:  Deepta Bhattacharya; Agnieszka Czechowicz; A G Lisa Ooi; Derrick J Rossi; David Bryder; Irving L Weissman
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

Review 10.  Space-time considerations for hematopoietic stem cell transplantation.

Authors:  Deepta Bhattacharya; Lauren I Richie Ehrlich; Irving L Weissman
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.